rs3812497

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024757.5(EHMT1):​c.444T>C​(p.Pro148Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.272 in 1,608,838 control chromosomes in the GnomAD database, including 62,643 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5098 hom., cov: 32)
Exomes 𝑓: 0.28 ( 57545 hom. )

Consequence

EHMT1
NM_024757.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.319

Publications

21 publications found
Variant links:
Genes affected
EHMT1 (HGNC:24650): (euchromatic histone lysine methyltransferase 1) The protein encoded by this gene is a histone methyltransferase that methylates the lysine-9 position of histone H3. This action marks the genomic region packaged with these methylated histones for transcriptional repression. This protein may be involved in the silencing of MYC- and E2F-responsive genes and therefore could play a role in the G0/G1 cell cycle transition. Defects in this gene are a cause of chromosome 9q subtelomeric deletion syndrome (9q-syndrome, also known as Kleefstra syndrome). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017]
EHMT1 Gene-Disease associations (from GenCC):
  • Kleefstra syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Kleefstra syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 9-137716984-T-C is Benign according to our data. Variant chr9-137716984-T-C is described in ClinVar as Benign. ClinVar VariationId is 65738.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.319 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.366 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EHMT1NM_024757.5 linkc.444T>C p.Pro148Pro synonymous_variant Exon 3 of 27 ENST00000460843.6 NP_079033.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EHMT1ENST00000460843.6 linkc.444T>C p.Pro148Pro synonymous_variant Exon 3 of 27 5 NM_024757.5 ENSP00000417980.1

Frequencies

GnomAD3 genomes
AF:
0.241
AC:
36622
AN:
152002
Hom.:
5091
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.117
Gnomad AMI
AF:
0.334
Gnomad AMR
AF:
0.374
Gnomad ASJ
AF:
0.346
Gnomad EAS
AF:
0.146
Gnomad SAS
AF:
0.307
Gnomad FIN
AF:
0.254
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.280
Gnomad OTH
AF:
0.252
GnomAD2 exomes
AF:
0.288
AC:
72036
AN:
249932
AF XY:
0.287
show subpopulations
Gnomad AFR exome
AF:
0.110
Gnomad AMR exome
AF:
0.483
Gnomad ASJ exome
AF:
0.350
Gnomad EAS exome
AF:
0.137
Gnomad FIN exome
AF:
0.252
Gnomad NFE exome
AF:
0.275
Gnomad OTH exome
AF:
0.277
GnomAD4 exome
AF:
0.275
AC:
400861
AN:
1456718
Hom.:
57545
Cov.:
37
AF XY:
0.277
AC XY:
200831
AN XY:
723724
show subpopulations
African (AFR)
AF:
0.109
AC:
3622
AN:
33354
American (AMR)
AF:
0.471
AC:
20976
AN:
44562
Ashkenazi Jewish (ASJ)
AF:
0.349
AC:
9090
AN:
26060
East Asian (EAS)
AF:
0.146
AC:
5767
AN:
39620
South Asian (SAS)
AF:
0.317
AC:
27374
AN:
86232
European-Finnish (FIN)
AF:
0.252
AC:
13198
AN:
52290
Middle Eastern (MID)
AF:
0.301
AC:
1732
AN:
5748
European-Non Finnish (NFE)
AF:
0.273
AC:
303183
AN:
1108644
Other (OTH)
AF:
0.264
AC:
15919
AN:
60208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
19333
38665
57998
77330
96663
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10174
20348
30522
40696
50870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.241
AC:
36649
AN:
152120
Hom.:
5098
Cov.:
32
AF XY:
0.244
AC XY:
18112
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.117
AC:
4868
AN:
41522
American (AMR)
AF:
0.375
AC:
5721
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.346
AC:
1200
AN:
3468
East Asian (EAS)
AF:
0.146
AC:
755
AN:
5170
South Asian (SAS)
AF:
0.309
AC:
1492
AN:
4824
European-Finnish (FIN)
AF:
0.254
AC:
2691
AN:
10598
Middle Eastern (MID)
AF:
0.289
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
0.280
AC:
19003
AN:
67948
Other (OTH)
AF:
0.251
AC:
529
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1405
2810
4216
5621
7026
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
390
780
1170
1560
1950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
9180
Bravo
AF:
0.244
Asia WGS
AF:
0.190
AC:
665
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 23, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

Kleefstra syndrome 1 Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Mar 11, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
6.2
DANN
Benign
0.67
PhyloP100
-0.32
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3812497; hg19: chr9-140611436; COSMIC: COSV58375053; COSMIC: COSV58375053; API